Inova Schar Cancer Institute is a clinical research site located in Falls Church, Virginia, United States 22042.
Crixeo Health Trust Score: 71/100 (FAIR). This profile has not yet been claimed by the site owner.
Inova Schar Cancer Institute has participated in 5 clinical trials with 4 currently active.
Therapeutic areas: Urinary Bladder Neoplasms, Neoplasm Metastasis, Ureteral Neoplasms.
Sponsors: Eli Lilly and Company, Incyte Corporation, Inova Health Care Services.
Trust Score: 71/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Inova Schar Cancer Institute has a Crixeo Trust Score of 71/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Inova Schar Cancer Institute has 5 clinical trials on record, with 4 currently active. Their work covers Urinary Bladder Neoplasms, Neoplasm Metastasis, Ureteral Neoplasms.
Yes — Inova Schar Cancer Institute holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.